ArticleVaccine: X2026
Parameters Affecting Dengue Virus Replication in Vero Cells.
Article in Vaccine: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Dengue has become a global threat affecting millions of people annually and contributing to a significant mortality burden. Vaccination is the most effective approach to prevent this disease in dengue-endemic regions. A thorough understanding of viral growth kinetics is critical for designing a robust and scalable vaccine manufacturing process. The current study aimed to optimize the key growth parameters of four recombinant live attenuated dengue serotypes, including harvest schedule, temperature, Multiplicity of infection (MOI), and metabolite concentration. Growth kinetics data, followed by a scale-up study, established the feasibility of multiple harvests for all four serotypes within a defined production window, with the first harvest optimally occurring between Days 4 and 8. All serotypes demonstrated strong responsiveness to low MOIs and temperature shifts, resulting in 2- to 25-fold increases in titer within a reduced time frame. Furthermore, metabolite profiling revealed distinct glutamine and glucose consumption dynamics, highlighting its importance for optimizing infection media. Taken together, these findings provide valuable insights into dengue virus production and define critical parameters that can support future optimization studies and large-scale production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.